Jude Onyia
Chief Tech/Sci/R&D Officer chez NEUROCRINE BIOSCIENCES, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Jude Onyia is currently the Director at Voyager Therapeutics, Inc. and the Chief Scientific Officer at Neurocrine Biosciences, Inc. Prior to his current roles, he worked at Eli Lilly & Co. for 26 years, where he held the position of Vice President-Biotechnology Discovery Research from 2014 to 2021.
He also briefly served as the Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Onyia received his undergraduate degree from The State University of New York and his doctorate from the State University of New York at Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2024 | 13 354 ( 0,01% ) | 2 M $ | 31/03/2024 | |
| 06/06/2023 | 2 910 ( 0,01% ) | 27 092 $ | 31/03/2024 |
Postes actifs de Jude Onyia
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/11/2021 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 21/02/2023 |
Anciens postes connus de Jude Onyia
| Sociétés | Poste | Fin |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2021 |
Formation de Jude Onyia
| The State University of New York | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
